Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities.  Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.

Biotechnology

Symphogen

Symphogen's headquarters in Ballerup, Denmark

Christophe Thurieau

Pia Holm Olesen

Malin Carlsson

Michael Herbst

Mads Laustsen

Ivan Horak

Rikke Bolding Jensen

Michael Rasmussen

Pascal Lemaire

Benoit Chéron

Claude Bertrand

Description

People (48)

Michael Rasmussen

Lennert Meelberg-Lange

Rikke Bolding Jensen

Claus Haase

Pia Holm Olesen

Henrik Heidelbach

Dorthe Sandager Bilde

Heidi Rønnest

Agnete Marie Granau

Anne Schlitterlau Knudsen

Anne-Sophie Grandvuinet

Anne Worsaae

Dan Bach Kristensen

Daniel Andersen

Daria Sergeeva

Ellen Sloth Wilhelmsen

Hanne Cservenka

Hedvig Sofie Hasemann

Jan Simonsen

Janus Schou Jakobsen

Jesper Buchhave Poulsen

Johan Ørskov Ipsen

Karsten Hartvigsen

Katrine Zinck L.

Lasse Toftdal Dynesen

Martin Alsted Bendz

Mathilde Bolding Andreasen

Nadia Mirza

Pontip Prasomsat Isager Henriksen

Randi Westh

Rasmus Jakobsen

Simone Oldenburg

Anne-Sofie Voss

Tania Køllgaard

Tine Ebstrup

Trine Meiborg Sloth

Viktoria Sereti

Klaus Koefoed

Christine Møller Pedersen

Jesper Lerche Jakobsen

Trine Lindsted

Mads Laustsen

Michael Herbst

Anette Aabo

Andrea Vala

Maria Carlsen Melander

Gorm Andersen

Pernille F.

Jobs